by Team Small News | Apr 10, 2025 | Pharma, Zydus
Zydus Lifesciences Limited, a global healthcare company, has announced its agreement to acquire a majority stake in Amplitude Surgical, a European surgical device maker specializing in lower-limb orthopedic technologies. Under the deal, Zydus Lifesciences will acquire...
by Team Small News | Apr 9, 2025 | Aurobindo Pharma, Pharma, Sun Pharma, Zydus
The US government, under President Donald Trump, has announced plans to impose new tariffs on pharmaceutical imports, which could significantly impact India, the top supplier of generic drugs to the US. The move aims to push pharmaceutical manufacturing back to the...
by Team Small News | Apr 1, 2025 | Aurobindo Pharma, Divi's Laboratories, Pharma, Sun Pharma, Torrent Pharma, Zydus
Citibank has analyzed the potential impact of US tariffs on Indian pharmaceutical companies and has assigned a low probability to such an event. The brokerage firm simulated a 10% tariff scenario and found that companies with a high exposure to US generics, such as...
by Team Small News | Mar 31, 2025 | Pharma, Zydus
Zydus Trust, a private charitable trust, has acquired a luxury flat in Mumbai’s Worli area for Rs 2 billion (approximately $27 million USD). The property, which spreads over 10,000 square feet, is situated in the upscale Worli district of Mumbai, known for its...
by Team Small News | Mar 29, 2025 | Pharma, Zydus
Mumbai’s real estate sector is experiencing a surge, with a record number of high-value sales driven by billionaires, Bollywood celebrities, and high net-worth individuals. One recent example is the Zydus Family Trust, a major shareholder in Zydus Lifesciences,...
by Team Small News | Mar 18, 2025 | Pharma, Zydus
Zydus Lifesciences has obtained final approval from the US Food and Drug Administration (USFDA) to manufacture Apalutamide Tablets, also known as Erleada Tablets, 60 mg. The drug is an androgen receptor inhibitor, primarily used to treat patients with metastatic...